MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617081857 A) filed by Takeda Vaccines, Inc. on July 02, 2026, for A Method For Determining The Concentration Of Residual Vero Cell Genomic Dna In A Sample Containing Virus Obtained From Production In Vero Cells.
Inventors include Livengood, Jill; Karwal, Lovkesh; and Crampon, Eric.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: The present invention relates to a method for determining the concentration of residual Vero cell genomic DNA in a sample containing virus obtained from production in Vero cells, and quality methods for determining the quality of in-process control (IPC) and end product control (EPC) samples in biopharmaceutical manufacturing processes.
Disclaimer: Curated by HT Syndication.
